Long term treatment of IgA nephropathy with cyclosporine A

Renal Failure

Volumn 22, Issue 1, 2000, Pages 55-62

  Chábová, Vera ^a,b   Tesar, Vladimir ^a   Zabka, Jiri ^a   Rychlik, Ivan ^a   Merta, Miroslav ^a   Jirsa Jr , Milan ^a   Stejskalová, Alena ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PREDNISONE;

ARTICLE; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; MALE; PREDNISONE; PROTEINURIA; TIME FACTORS;

EID: 0343851556     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100100851     Document Type: Article

References (21)

1. D'Amico G: The commonest glomerulonephritis in the world IgA nephropathy. Quart J Med 64:709-727, 1987.
2. Rychlik I, Tesar V za Ceskou koperativni skupinu pro studium glomerulonefritidy 1995 Bioptická aktivita v Ceské republice 1994 (Bioptical activity in Czech Republic 1994. Presented at the 25 Czech Nephrological Congress, Prague, 1995.
3. Schena FP: IgA nephropathies. In: Cameron S, Davison AM, Gruenfeld J-P, Kerr D, Ritz E (eds); Oxford textbook of clinical nephrology. Oxford, Oxford University Press, 1992, pp 339-369.
4. Donadio JV, Bergstralh EJ, Offord KP: A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331:1194-1199, 1994.
5. Ferri C, Puccini R, Logombardo G, Paleologo G, Migliorini P, Moriconi L, Pasero G: Low-antigen-content diet in the treatment of patients with IgA nephropathy. Nephrol Dial Transplant 8:1193-1198, 1993.
6. Goumenos D, Ahuja IA, Shortland JR, Brown CB: Can immunosuppressive drugs slow the progression of IgA nephropathy? Nephrol Dial Transplant 10:1173-1181, 1995.
7. Walker RG, Yu SH, Owen JE, Kincaid-Smith P: The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: A two year prospective trial. Clin Nephrol 34:103-107, 1990.
8. Lai KN, Lai FM, Li PL, Vallence-Owen J: Gyclosporine treatment of IgA nephropathy: A short-term controlled trial. Br Med J 295:1165-1168, 1987.
9. Galla JH: IgA nephroparhy. Kidney Int 47:377-387, 1995.
10. Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccal A, Zuccheli P: ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant 9:265-269, 1994.
11. Cattran et al.: Long term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment agents and to patients receiving no therapy. Am J Kidney Dis 23:247-254, 1994.
12. Rostoker G, Desvaux-Belghiti D, Pilatte Y, Petit-Phar M, Phillpon C, Desforges L, Terzidis H, Intrator L, Andre C, Adnot S, Bonin P, Bierling P, Remy P, Lagrue G, Weil B: High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schoenlein purpura. Ann Int Med 120:476-484, 1994.
13. Roccatello D, Ferro M, Coppo R, Giraudo G, Quattrocchio G, Piccoli G: Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant 10:2054-2059, 1995.
14. Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ: Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309-312, 1994.
15. Berger J: Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12:371-372, 1988.
16. Kobayashi Y, Hiki Y, Fujii K, Kurokawa A. Tateno S: Moderately proteinuric IgA nephropathy: Prognostic prediction of individual clinical courses and steroid therapy in progressive cases. Nephron 53:250-256, 1989.
17. Ambalavanan S, Fauvel J-P, Sibley RK, Myers BD: Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephroll 7:290-298, 1996.
18. Zietse R, Derkx FHM, Schalekamp MADH, Weimar W: Cyclosporine and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy. In: Tejani A (ed); Cyclosporine in the therapy of renal disease (Contributions to Nephrology, vol 114), Basel, Karger, 1995, pp 6-18.
19. Berden JHM, Schrijver G, Desassis JF, van der Born J: Cyclosporine A (CsA) in experimental models of proteinuria Mechanisms of the antiproteinuric effect. Presented at the XIIth International Congress of Nephrology, Jerusalem, 1993.
20. Meyrier A: Use of cyclosporine in the treatment of idiopathic nephrotic syndrome. In: Tejani A (ed); Cyclosporine in the therapy of renal disease (Contributions to Nephrology, vol. 114), Basel. Karger, 1995, pp 28-38.
21. Cattran DC: Use of cyclosporine in membranous and mesangioproliferative nephropathy. In: Tejani A (ed); Cyclosporin in the therapy of renal disease (Contributions to Nephrology, vol 114), Basel, Karger, 1995, pp 49-58.